GlassScriptPhysician profile
Robert Allan Hodgson
NPI 1437252459
$8,201.80
in general payments reported to CMS, 2019-2025
47 companies · $140 in 2025
The $140 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,302 · 2020: $1,422 · 2021: $1,580 · 2022: $1,474 · 2023: $1,420 · 2024: $863 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,423.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,244.56 | 2019-2025 | |
| Novo Nordisk INC | $670.63 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Amarin Pharma, INC. | $645.54 | 2019-2023 | |
| Lilly USA, LLC | $616.73 | 2019-2024 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $497.11 | 2019-2024 | Jardiance |
| Amgen INC. | $442.50 | 2019-2024 | Repatha, Otezla |
| Astrazeneca Pharmaceuticals LP | $387.95 | 2019-2023 | Breztri |
| Glaxosmithkline, LLC. | $375.60 | 2020-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $317.29 | 2019-2025 | |
| Abbott Laboratories | $284.57 | 2020-2025 | Freestyle Libre 3, Gallant |
| Merck Sharp & Dohme LLC | $275.14 | 2019-2022 | |
| Allergan, INC. | $237.70 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $227.56 | 2019-2023 | Livalo, Seglentis |
| Genentech USA, INC. | $174.24 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $139.29 | 2019-2023 | Xarelto |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Hodgson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.